Hematopoietic stem and progenitor cells (HSPCs) reside in bone marrow (BM) in an environment rich in CXCL12, the ligand for CXCR4, which is constitutively expressed on all immature hematopoietic cells in BM. This ligand-receptor pair critically controls HSPC retention and (relative) quiescence in BM. Interestingly, in a chemokine-abundant environment, CXCR4 surface expression and CXCL12 sensitivity of BM-residing HSPCs are continuously maintained. The mechanisms underlying this peculiar pattern of G-protein signal integration by BM-HSPCs are unknown. G-protein receptor kinases (GRKs) control receptor function by phosphorylating the intracellular domains upon ligand-induced activation, which results in receptor internalization and transient refractoriness. Using, therefore, a GRK6-deficient (GRK6−/−) mouse, we sought to address how perturbed ligand-induced CXCR4 (in)activation affects HSPC behavior in vitro and in vivo. In vitro, GRK6−/− HSPCs were characterized by hyper-responsiveness to CXCL12, as expected. In vivo, GRK6−/− immature hematopoiesis was characterized by a marked expansion of immature hematopoiesis in spleens and a modest repopulation defect in serial competitive transplantation. Enforced mobilization with granulocyte colony-stimulating factor (G-CSF) and AMD3100 was normal, as was hematopoietic regeneration after noncompetitive transplantation or pharmacological myelosuppression. These observations illustrate that GRK-mediated restriction of CXCR4 signal input after ligand engagement is largely dispensable for BM-resident HSPCs, which may explain how continuous CXCL12 responsiveness of BM-HSPCs can be maintained.
Get full access to this article
View all access options for this article.
References
1.
BonigH, ChudziakD, PriestleyG and PapayannopoulouT. (2009). Insights into the biology of mobilized hematopoietic stem/progenitor cells through innovative treatment schedules of the CXCR4 antagonist AMD3100. Exp Hematol, 37:402–415.
2.
BroxmeyerHE, OrschellCM, ClappDW, HangocG, CooperS, PlettPA, LilesWC, LiX, Graham-EvansB, et al. (2005). Rapid mobilization of murine and human hematopoietic stem and progenitor cells with AMD3100, a CXCR4 antagonist. J Exp Med, 201:1307–1318.
3.
De ClercqE. (2009). The AMD3100 story: the path to the discovery of a stem cell mobilizer (Mozobil). Biochem Pharmacol, 77:1655–1664.
4.
FoudiA, JarrierP, ZhangY, WittnerM, GeayJF, LecluseY, NagasawaT, VainchenkerW and LouacheF. (2006). Reduced retention of radioprotective hematopoietic cells within the bone marrow microenvironment in CXCR4−/− chimeric mice. Blood, 107:2243–2251.
5.
NieY, HanYC and ZouYR. (2008). CXCR4 is required for the quiescence of primitive hematopoietic cells. J Exp Med, 205:777–783.
6.
BusilloJM and BenovicJL. (2007). Regulation of CXCR4 signaling. Biochim Biophys Acta, 1768:952–963.
7.
BusilloJM, ArmandoS, SenguptaR, MeucciO, BouvierM and BenovicJL. (2010). Site-specific phosphorylation of CXCR4 is dynamically regulated by multiple kinases and results in differential modulation of CXCR4 signaling. J Biol Chem, 285:7805–7817.
8.
CrumpMP, GongJH, LoetscherP, RajarathnamK, AmaraA, Arenzana-SeisdedosF, VirelizierJL, BaggioliniM, SykesBD and Clark-LewisI. (1997). Solution structure and basis for functional activity of stromal cell-derived factor-1; dissociation of CXCR4 activation from binding and inhibition of HIV-1. EMBO J, 16:6996–7007.
9.
DeWireSM, AhnS, LefkowitzRJ and ShenoySK. (2007). Beta-arrestins and cell signaling. Annu Rev Physiol, 69:483–510.
10.
GainetdinovRR, PremontRT, BohnLM, LefkowitzRJ and CaronMG. (2004). Desensitization of G protein-coupled receptors and neuronal functions. Annu Rev Neurosci, 27:107–144.
11.
HuangX, ShenJ, CuiM, ShenL, LuoX, LingK, PeiG, JiangH and ChenK. (2003). Molecular dynamics simulations on SDF-1alpha: binding with CXCR4 receptor. Biophys J, 84:171–184.
12.
KrupnickJG and BenovicJL. (1998). The role of receptor kinases and arrestins in G protein-coupled receptor regulation. Annu Rev Pharmacol Toxicol, 38:289–319.
13.
MooreCA, MilanoSK and BenovicJL. (2007). Regulation of receptor trafficking by GRKs and arrestins. Annu Rev Physiol, 69:451–482.
14.
PitcherJA, FreedmanNJ and LefkowitzRJ. (1998). G protein-coupled receptor kinases. Annu Rev Biochem, 67:653–692.
15.
PremontRT and GainetdinovRR. (2007). Physiological roles of G protein-coupled receptor kinases and arrestins. Annu Rev Physiol, 69:511–534.
16.
ReiterE and LefkowitzRJ. (2006). GRKs and beta-arrestins: roles in receptor silencing, trafficking and signaling. Trends Endocrinol Metab, 17:159–165.
17.
FongAM, PremontRT, RichardsonRM, YuYR, LefkowitzRJ and PatelDD. (2002). Defective lymphocyte chemotaxis in beta-arrestin2- and GRK6-deficient mice. Proc Natl Acad Sci U S A, 99:7478–7483.
18.
VroonA, HeijnenCJ, RaatgeverR, TouwIP, PloemacherRE, PremontRT and KavelaarsA. (2004). GRK6 deficiency is associated with enhanced CXCR4-mediated neutrophil chemotaxis in vitro and impaired responsiveness to G-CSF in vivo. J Leukoc Biol, 75:698–704.
19.
NakayaM, TajimaM, KosakoH, NakayaT, HashimotoA, WatariK, NishiharaH, OhbaM, KomiyaS, et al. (2013). GRK6 deficiency in mice causes autoimmune disease due to impaired apoptotic cell clearance. Nat Commun, 4:1532
20.
EijkelkampN, HeijnenCJ, LucasA, PremontRT, ElsenbruchS, SchedlowskiM and KavelaarsA. (2007). G protein-coupled receptor kinase 6 controls chronicity and severity of dextran sodium sulphate-induced colitis in mice. Gut, 56:847–854.
21.
Jean-AlphonseF and HanyalogluAC. (2011). Regulation of GPCR signal networks via membrane trafficking. Mol Cell Endocrinol, 331:205–214.
22.
MohleR and DrostAC. (2012). G protein-coupled receptor crosstalk and signaling in hematopoietic stem and progenitor cells. Ann N Y Acad Sci, 1266:63–67.
Mendez-FerrerS, LucasD, BattistaM and FrenettePS. (2008). Haematopoietic stem cell release is regulated by circadian oscillations. Nature, 452:442–447.
25.
BasuS and BroxmeyerHE. (2005). Transforming growth factor-{beta}1 modulates responses of CD34+ cord blood cells to stromal cell-derived factor-1/CXCL12. Blood, 106:485–493.
26.
GainetdinovRR, BohnLM, SotnikovaTD, CyrM, LaaksoA, MacraeAD, TorresGE, KimKM, LefkowitzRJ, CaronMG and PremontRT. (2003). Dopaminergic supersensitivity in G protein-coupled receptor kinase 6-deficient mice. Neuron, 38:291–303.
27.
KavelaarsA, VroonA, RaatgeverRP, FongAM, PremontRT, PatelDD, LefkowitzRJ and HeijnenCJ. (2003). Increased acute inflammation, leukotriene B4-induced chemotaxis, and signaling in mice deficient for G protein-coupled receptor kinase 6. J Immunol, 171:6128–6134.
28.
KarpovaD, DauberK, SpohnG, ChudziakD, WiercinskaE, SchulzM, PettitAR, LevesqueJP, RomagnoliB, et al. (2013). The novel CXCR4 antagonist POL5551 mobilizes hematopoietic stem and progenitor cells with greater efficiency than Plerixafor. Leukemia, 27:2322–2331.
29.
BonigH, PriestleyGV, NilssonLM, JiangY and PapayannopoulouT. (2004). PTX-sensitive signals in bone marrow homing of fetal and adult hematopoietic progenitor cells. Blood, 104:2299–2306.
30.
BonigH, PriestleyGV and PapayannopoulouT. (2006). Hierarchy of molecular-pathway usage in bone marrow homing and its shift by cytokines. Blood, 107:79–86.
31.
KoloninM and SimmonsP, eds. (2012). Stem Cell Mobilization—Methods in Molecular Biology, Vol. 904. Humana Press, New York, NY.
32.
OrlicD, KajsturaJ, ChimentiS, LimanaF, JakoniukI, QuainiF, Nadal-GinardB, BodineDM, LeriA and AnversaP. (2001). Mobilized bone marrow cells repair the infarcted heart, improving function and survival. Proc Natl Acad Sci U S A, 98:10344–10349.
33.
BonigH, PriestleyGV, OehlerV and PapayannopoulouT. (2007). Hematopoietic progenitor cells (HPC) from mobilized peripheral blood display enhanced migration and marrow homing compared to steady-state bone marrow HPC. Exp Hematol, 35:326–334.
34.
HeaveyB, CharalambousC, CobaledaC and BusslingerM. (2003). Myeloid lineage switch of Pax5 mutant but not wild-type B cell progenitors by C/EBPalpha and GATA factors. EMBO J, 22:3887–3897.
35.
GeigerH, TrueJM, de HaanG and Van ZantG. (2001). Age- and stage-specific regulation patterns in the hematopoietic stem cell hierarchy. Blood, 98:2966–2972.
36.
LiangY, Van ZantG and SzilvassySJ. (2005). Effects of aging on the homing and engraftment of murine hematopoietic stem and progenitor cells. Blood, 106:1479–1487.
37.
WaterstratA and Van ZantG. (2009). Effects of aging on hematopoietic stem and progenitor cells. Curr Opin Immunol, 21:408–413.
38.
Lo CelsoC, FlemingHE, WuJW, ZhaoCX, Miake-LyeS, FujisakiJ, CoteD, RoweDW, LinCP and ScaddenDT. (2009). Live-animal tracking of individual haematopoietic stem/progenitor cells in their niche. Nature, 457:92–96.
39.
JiangY, BonigH, UlyanovaT, ChangK and PapayannopoulouT. (2009). On the adaptation of endosteal stem cell niche function in response to stress. Blood, 114:3773–3782.
40.
LaiCY, YamazakiS, OkabeM, SuzukiS, MaeyamaY, IimuraY, OnoderaM, KakutaS, IwakuraY, et al. (2014). Stage-specific roles for Cxcr4 signaling in murine hematopoietic stem/progenitor cells in the process of bone marrow repopulation. Stem Cells, 32:1929–1942.
41.
PurtonLE and ScaddenDT. (2007). Limiting factors in murine hematopoietic stem cell assays. Cell Stem Cell, 1:263–270.
42.
WaterstratA, LiangY, SwiderskiCF, SheltonBJ and Van ZantG. (2010). Congenic interval of CD45/Ly-5 congenic mice contains multiple genes that may influence hematopoietic stem cell engraftment. Blood, 115:408–417.
43.
BasuS, RayA and DittelBN. (2013). Differential representation of B cell subsets in mixed bone marrow chimera mice due to expression of allelic variants of CD45 (CD45.1/CD45.2). J Immunol Methods, 396:163–167.
44.
RandallTD and WeissmanIL. (1997). Phenotypic and functional changes induced at the clonal level in hematopoietic stem cells after 5-fluorouracil treatment. Blood, 89:3596–3606.
45.
AdamJ and RosendaalM. (1987). Patterns of recovery of high proliferation potential colony-forming cells after stressing the haemopoietic system—I. Leuk Res, 11:421–427.
46.
HendryJH. (1985). The cellular basis of long-term marrow injury after irradiation. Radiother Oncol, 3:331–338.
47.
ScottLM, PriestleyGV and PapayannopoulouT. (2003). Deletion of alpha4 integrins from adult hematopoietic cells reveals roles in homeostasis, regeneration, and homing. Mol Cell Biol, 23:9349–9360.
48.
LevesqueJP, HendyJ, TakamatsuY, SimmonsPJ and BendallLJ. (2003). Disruption of the CXCR4/CXCL12 chemotactic interaction during hematopoietic stem cell mobilization induced by GCSF or cyclophosphamide. J Clin Invest, 111:187–196.
49.
WinklerIG, PettitAR, RaggattLJ, JacobsenRN, ForristalCE, BarbierV, NowlanB, CisterneA, BendallLJ, SimsNA and LevesqueJP. (2012). Hematopoietic stem cell mobilizing agents G-CSF, cyclophosphamide or AMD3100 have distinct mechanisms of action on bone marrow HSC niches and bone formation. Leukemia, 26:1594–1601.
50.
RamirezP, RettigMP, UyGL, DeychE, HoltMS, RitcheyJK and DiPersioJF. (2009). BIO5192, a small molecule inhibitor of VLA-4, mobilizes hematopoietic stem and progenitor cells. Blood, 114:1340–1343.
51.
LoudonRP, PerussiaB and BenovicJL. (1996). Differentially regulated expression of the G-protein-coupled receptor kinases, betaARK and GRK6, during myelomonocytic cell development in vitro. Blood, 88:4547–4557.
52.
TarrantTK, BillardMJ, TimoshchenkoRG, McGinnisMW, SerafinDS, ForemanO, EssermanDA, ChaoNJ, LentoWE, et al. (2013). G protein-coupled receptor kinase-3-deficient mice exhibit WHIM syndrome features and attenuated inflammatory responses. J Leukoc Biol, 94:1243–1251.
53.
HernandezPA, GorlinRJ, LukensJN, TaniuchiS, BohinjecJ, FrancoisF, KlotmanME and DiazGA. (2003). Mutations in the chemokine receptor gene CXCR4 are associated with WHIM syndrome, a combined immunodeficiency disease. Nat Genet, 34:70–74.
54.
KawaiT, ChoiU, Whiting-TheobaldNL, LintonGF, BrennerS, SechlerJM, MurphyPM and MalechHL. (2005). Enhanced function with decreased internalization of carboxy-terminus truncated CXCR4 responsible for WHIM syndrome. Exp Hematol, 33:460–468.
55.
McCormickPJ, SegarraM, GasperiniP, GulinoAV and TosatoG. (2009). Impaired recruitment of Grk6 and beta-Arrestin 2 causes delayed internalization and desensitization of a WHIM syndrome-associated CXCR4 mutant receptor. PLoS One, 4:e8102
56.
BalabanianK, BrotinE, BiajouxV, Bouchet-DelbosL, LaineyE, FenneteauO, BonnetD, FietteL, EmilieD and BachelerieF. (2012). Proper desensitization of CXCR4 is required for lymphocyte development and peripheral compartmentalization in mice. Blood, 119:5722–5730.
57.
TakizawaH, RegoesRR, BoddupalliCS, BonhoefferS and ManzMG. (2011). Dynamic variation in cycling of hematopoietic stem cells in steady state and inflammation. J Exp Med, 208:273–284.
58.
MorrisonSJ, UchidaN and WeissmanIL. (1995). The biology of hematopoietic stem cells. Annu Rev Cell Dev Biol, 11:35–71.
59.
GreenbaumAM and LinkDC. (2011). Mechanisms of G-CSF-mediated hematopoietic stem and progenitor mobilization. Leukemia, 25:211–217.
Supplementary Material
Please find the following supplemental material available below.
For Open Access articles published under a Creative Commons License, all supplemental material carries the same license as the article it is associated with.
For non-Open Access articles published, all supplemental material carries a non-exclusive license, and permission requests for re-use of supplemental material or any part of supplemental material shall be sent directly to the copyright owner as specified in the copyright notice associated with the article.
